With the exception of those medicinal products which are subject to the centralized Community authorization procedure established by Council Regulation (EEC) No 2309/93 of 22 July 1993 laying down Community procedures for the authorization and supervision of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products(14) a marketing authorization for a medicinal product granted by a competent authority in one Member State ought to be recognized by the competent authorities of the other Member States unless there are serious grounds for supposing that the authorization of the medicinal product concerned may present a risk to public health. In the event of a disagreement between Member States about the quality, the safety or the efficacy of a medicinal product, a scientific evaluation of the matter should be undertaken according to a Community standard, leading to a single decision on the area of disagreement binding on the Member States concerned. Whereas this decision should be adopted by a rapid procedure ensuring close cooperation between the Commission and the Member States.
Recital 12, Directive (EU) 2001/83
The 10 that are cited most themselves, of 11.
Judgment of the Court (First Chamber) of 16 October 2008. The Queen, on the application of Synthon BV v Licensing Authority of the DepartmenDecision
That is particularly true as regards the procedure for mutual recognition established by Article 28 of Directive 2001/83. In accordance with the objective of abolishing all barriers to the free movement of medicinal products in the …
16 Oct 2008 · 62006CJ0452
Judgment of the General Court (Seventh Chamber, Extended Composition) of 5 May 2021. Pharmaceutical Works Polpharma S.A. v European MedicineDecision
Lastly, it should be noted that, according to recital 12 of Directive 2001/83, in the event of a disagreement between Member States about the quality, the safety or the efficacy of a medicinal product, a scientific evaluation of the matter …
5 May 2021 · 62018TJ0611
Judgment of the General Court (Ninth Chamber) of 12 December 2018. Niche Generics Ltd v European Commission.Decision
As regards the barrier represented by the fact that marketing authorisations had not been obtained in any Member States other than the United Kingdom, it must be pointed out that there is a mutual recognition procedure under which the …
12 Dec 2018 · 62014TJ0701
Judgment of the General Court (Ninth Chamber) of 12 December 2018. Unichem Laboratories Ltd v European Commission.Decision
As regards the barrier represented by the fact that marketing authorisations had not been obtained in any Member States other than the United Kingdom, it must be pointed out that there is a mutual recognition procedure under which the …
12 Dec 2018 · 62014TJ0705
Opinion of Advocate General Jääskinen delivered on 29 September 2011. European Commission v Republic of Poland.Decision
Directive 2001/83 provides for the mutual recognition of marketing authorisations granted in other Member States thereby ensuring that marketing authorisation can be applied for in several Member States without subjecting the medicinal …
29 Sep 2011 · 62010CC0185
Opinion of Advocate General Medina delivered on 6 October 2022. European Commission and Others v Pharmaceutical Works Polpharma S.A.Decision
Recitals 9 and 12 of Directive 2001/83 state: Experience has shown that it is advisable to stipulate more precisely the cases in which the results of toxicological and pharmacological tests or clinical trials do not have to be provided …
6 Oct 2022 · 62021CC0438
Opinion of Advocate General Szpunar delivered on 20 May 2021. Pharma Expressz Szolgáltató és Kereskedelmi Kft v Országos Gyógyszerészeti és Decision
It is true that recital 12 of Directive 2001/83 states, inter alia, that a marketing authorisation granted by a competent authority in one Member State ought to be recognised by the competent authorities of the other Member States, unless …
20 May 2021 · 62020CC0178
Judgment of the Court of First Instance (Second Chamber, extended composition) of 26 November 2002. Artegodan GmbH and Others v Commission oDecision
It must be stated in this respect that the purpose of the mutual recognition procedure militates against a literal interpretation of Article 10(2) of Directive 75/319 which would preclude application of the procedure provided for in …
26 Nov 2002 · 62000TJ0074
Judgment of the Court (Fourth Chamber) of 16 March 2023. European Commission and Others v Pharmaceutical Works Polpharma S.A.Decision
Recitals 9 and 12 of Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (OJ 2001 L 311, p. 67), as amended by Directive 2012/26/EU of the …
16 Mar 2023 · 62021CJ0438
Judgment of the Court (Fourth Chamber) of 8 July 2021. Pharma Expressz Szolgáltató és Kereskedelmi Kft v Országos Gyógyszerészeti és ÉlelmezDecision
Recital 12 of Directive 2001/83 states: ‘With the exception of those medicinal products which are subject to the centralized Community authorization procedure established by Council Regulation (EEC) No 2309/93 of 22 July 1993 laying down …
8 Jul 2021 · 62020CJ0178
- celex=31993R2309
- celex=31998R0649